Group B streptococcal infection is a major cause of neonatal mortality. Antibody to the capsular polysaccharide protects against invasive neonatal disease, but immunization with capsular polysaccharides fails to elicit protective antibody in many recipients. Conjugation of the polysaccharide to tetanus toxoid has been shown to increase immune response to the polysaccharide. In animal models, C proteins of group B streptococci are also protective determinants. We examined the ability of the beta C protein to serve in the dual role of carrier for the polysaccharide and protective immunogen. Type III polysaccharide was covalently coupled to beta C protein by reductive amination. Immunization of rabbits with the polysaccharide-protein conjugate elicited high titers of antibody to both components, and the serum induced opsonophagocytic killing of type III, Ia/C, and Ib/C strains of group B streptococci. Female mice were immunized with the conjugate vaccine and then bred; 93% of neonatal pups born to these dams vaccinated with conjugate survived type III group B streptococcal challenge and 76% survived type Ia/C challenge, compared with 3% and 8% survival, respectively, in controls (P < 0.001). The beta C protein acted as an effective carrier for the type III polysaccharide while simultaneously induced protective immunity against beta C protein--containing strains of group B streptococci.
L C Madoff, L C Paoletti, J Y Tai, D L Kasper
Title and authors | Publication | Year |
---|---|---|
Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines
Duan H, Huang W, Lv Q, Liu P, Li Q, Kong D, Sun X, Zhang X, Jiang Y, Chen S |
Human vaccines | 2024 |
Vaccines for Perinatal and Congenital Infections—How Close Are We?
T Singh, CE Otero, K Li, SM Valencia, AN Nelson, SR Permar |
Frontiers in Pediatrics | 2020 |
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations
J Vekemans, J Crofts, CJ Baker, D Goldblatt, PT Heath, SA Madhi, KL Doare, N Andrews, AJ Pollard, SK Saha, SJ Schrag, PG Smith, DC Kaslow |
Vaccine | 2019 |
Gram-Positive Pathogens
VA Fischetti, RP Novick, JJ Ferretti, DA Portnoy, M Braunstein, JI Rood |
2019 | |
Surface Structures of Group B Streptococcus Important in Human Immunity
LC Paoletti, DL Kasper, VA Fischetti, RP Novick, JJ Ferretti, DA Portnoy, M Braunstein, JI Rood |
Microbiology spectrum | 2019 |
Streptococcus agalactiae Non-Pilus, Cell Wall-Anchored Proteins: Involvement in Colonization and Pathogenesis and Potential as Vaccine Candidates
G Pietrocola, CR Arciola, S Rindi, L Montanaro, P Speziale |
Frontiers in immunology | 2018 |
Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy
S Dzanibe, G Kwatra, PV Adrian, SZ Kimaro-Mlacha, CL Cutland, SA Madhi |
Scientific Reports | 2017 |
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries
M Kobayashi, J Vekemans, CJ Baker, AJ Ratner, KL Doare, SJ Schrag |
F1000Research | 2016 |
Maternal vaccination: moving the science forward
AN Faucette, BL Unger, B Gonik, K Chen |
Human Reproduction Update | 2014 |
Current Status of Vaccine Development for Group B Streptococcus
KM Puopolo |
NeoReviews | 2014 |
Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III
SH Pincus, E Moran, G Maresh, HJ Jennings, DG Pritchard, ML Egan, O Blixt |
Vaccine | 2012 |
Infectious Diseases of the Fetus and Newborn
V Nizet, JS Bradley |
Infectious Diseases of the Fetus and Newborn | 2011 |
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
VG Fowler, WM Scheld, AS Bayer |
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases | 2010 |
Streptococcus adherence and colonization
AH Nobbs, RJ Lamont, HF Jenkinson |
Microbiology and molecular biology reviews : MMBR | 2009 |
Human pathogenic streptococcal proteomics and vaccine development
JN Cole, A Henningham, CM Gillen, V Ramachandran, MJ Walker |
PROTEOMICS – CLINICAL APPLICATIONS | 2008 |
Recombinant Group B Streptococcus Alpha-Like Protein 3 Is an Effective Immunogen and Carrier Protein
HH Yang, SJ Mascuch, LC Madoff, LC Paoletti |
Clinical and vaccine immunology : CVI | 2008 |
Recombinant Group B Streptococcus Beta C Protein and a Variant with the Deletion of Its Immunoglobulin A-Binding Site Are Protective Mouse Maternal Vaccines and Effective Carriers in Conjugate Vaccines
HH Yang, LC Madoff, HK Guttormsen, YD Liu, LC Paoletti |
Infection and immunity | 2007 |
Adjacent location of thebac gene and two-component regulatory system genes within the putativeStreptococcus agalactiae pathogenicity island
A Dmitriev, YH Yang, AD Shen, A Totolian |
Folia Microbiologica | 2006 |
Group B Streptococcus: global incidence and vaccine development
AK Johri, LC Paoletti, P Glaser, M Dua, PK Sharma, G Grandi, R Rappuoli |
Nature Reviews Microbiology | 2006 |
Infectious Diseases of the Fetus and Newborn Infant
RC Orscheln, HR Shinefield, JW st. Geme |
Infectious Diseases of the Fetus and Newborn Infant | 2006 |
The Prokaryotes
M Dworkin, S Falkow, E Rosenberg, KH Schleifer, E Stackebrandt |
2006 | |
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens
G Lindahl, M Stålhammar-Carlemalm, T Areschoug |
Clinical microbiology reviews | 2005 |
Vaccination against Group B streptococcus
PT Heath, RG Feldman |
Expert Review of Vaccines | 2005 |
Group B Streptococcal Colonization and Serotype-Specific Immunity in Healthy Elderly Persons
MS Edwards, MA Rench, DL Palazzi, CJ Baker |
Clinical Infectious Diseases | 2005 |
Immunology of the Fetus and Newborn
CB Williams, FS Cole |
Avery s Diseases of the Newborn | 2005 |
Mucosal Immunology
WR Brown |
Mucosal Immunology | 2005 |
Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria
MY Richter, H Jakobsen, A Birgisdottir, JF Haeuw, UF Power, GD Giudice, A Bartoloni, I Jonsdottir |
Infection and immunity | 2004 |
Glycoconjugate vaccines to prevent group B streptococcal infections
LC Paoletti, DL Kasper |
Expert Opinion on Biological Therapy | 2003 |
Mucosal Vaccination Against Encapsulated Respiratory Bacteria - New Potentials for Conjugate Vaccines?
H Jakobsen, I Jonsdottir |
Scandinavian Journal of Immunology | 2003 |
New Bacterial Vaccines
RW Ellis, BR Brodeur |
2003 | |
Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein
D Martin, S Rioux, E Gagnon, M Boyer, J Hamel, N Charland, BR Brodeur |
Infection and immunity | 2002 |
Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice
Q Cheng, S Debol, H Lam, R Eby, L Edwards, Y Matsuka, SB Olmsted, PP Cleary |
Infection and immunity | 2002 |
Polymorphisms in the Cell Wall–Spanning Domain of the C Protein β-Antigen in Clinical Streptococcus agalactiae Isolates Are Caused by Genetic Instability of Repeating DNA Sequences
R Berner, M Ruess, S Bereswill, M Brandis |
Pediatric Research | 2002 |
Vaccines to prevent neonatal GBS infection
LC Paoletti, LC Madoff |
Seminars in Neonatology | 2002 |
A Proline-Rich Region with a Highly Periodic Sequence in Streptococcal β Protein Adopts the Polyproline II Structure and Is Exposed on the Bacterial Surface
T Areschoug, S Linse, M Stålhammar-Carlemalm, LO Hedén, G Lindahl |
Journal of bacteriology | 2002 |
A proline-rich region with a highly periodic sequence in Streptococcal beta protein adopts the polyproline II structure and is exposed on the bacterial surface.
Areschoug T, Linse S, Stålhammar-Carlemalm M, Hedén LO, Lindahl G |
Journal of bacteriology | 2002 |
Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen
LC Paoletti, DL Peterson, R Legmann, RJ Collier |
Vaccine | 2001 |
Potency of clinical group B streptococcal conjugate vaccines
LC Paoletti |
Vaccine | 2001 |
Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate
X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, G Wallerström, J Holmgren |
Vaccine | 2001 |
Vaccines in Pregnancy
FM Munoz, JA Englund |
Infectious Disease Clinics of North America | 2001 |
Antibody against Surface-Bound C5a Peptidase Is Opsonic and Initiates Macrophage Killing of Group B Streptococci
EI Tuomanen, Q Cheng, B Carlson, S Pillai, R Eby, L Edwards, SB Olmsted, P Cleary |
Infection and immunity | 2001 |
Group B Streptococcus Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccines Prepared by Different Methods for Intranasal Immunization
EI Tuomanen, X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, J Holmgren |
Infection and immunity | 2001 |
Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide–cholera toxin B subunit conjugate vaccine for intranasal immunization
X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, J Holmgren |
Vaccine | 2000 |
Pathogenesis of neonatal Streptococcusagalactiae infections
B Spellerberg |
Microbes and Infection | 2000 |
Persistent Bacterial Infections
JP Nataro, MJ Blaser, S Cunningham-Rundles |
2000 | |
AnEscherichia coli-Enterococcus faecalisshuttle vector as a tool for the construction of a group BStreptococcusheterologous mutant expressing the β antigen (Bac) of the C protein complex
B Kreikemeyer, PG Jerlström |
FEMS Microbiology Letters | 1999 |
Neonatal group B streptococcal disease in Finland: a ten-year nationwide study
S Kalliola, J Vuopio-Varkila, AK Takala, J Eskola |
The Pediatric Infectious Disease Journal | 1999 |
Properties and distribution of the putative R3 protein ofStreptococcus agalactiae
AI Kvam, L Bevanger, JA Maeland |
APMIS | 1999 |
Alpha C Protein as a Carrier for Type III Capsular Polysaccharide and as a Protective Protein in Group B Streptococcal Vaccines
VA Fischetti, C Gravekamp, DL Kasper, LC Paoletti, LC Madoff |
Infection and immunity | 1999 |
Lmb, a Protein with Similarities to the LraI Adhesin Family, Mediates Attachment of Streptococcus agalactiae to Human Laminin
EI Tuomanen, B Spellerberg, E Rozdzinski, S Martin, J Weber-Heynemann, N Schnitzler, R Lütticken, A Podbielski |
Infection and immunity | 1999 |
Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins
RK Sood, A Fattom |
Expert Opinion on Investigational Drugs | 1998 |
Cervical Secretions in Pregnant Women Colonized Rectally with Group B Streptococci have High Levels of Antibodies to Serotype III Polysaccharide Capsular Antigen and Protein R
Hordnes, Tynning, Kvam, Bevanger, Brown, Jonsson, Haneberg |
Scandinavian Journal of Immunology | 1998 |
Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy
MR Wessels, LC Paoletti, HK Guttormsen, F Michon, AJ D'Ambra, DL Kasper |
Infection and immunity | 1998 |
Vaccines: From Concept to Clinic: A Guide to the Development and Clinical Testing of Vaccines for Human Use
A Onderdonk, R Kennedy |
Vaccines: From Concept to Clinic: A Guide to the Development and Clinical Testing of Vaccines for Human Use | 1998 |
Structural Properties of Group B Streptococcal Type III Polysaccharide Conjugate Vaccines That Influence Immunogenicity and Efficacy
MR Wessels, LC Paoletti, HK Guttormsen, F Michon, AJ DAmbra, DL Kasper |
Infection and immunity | 1998 |
Prospects for Vaccines During Pregnancy and in the Newborn Period
GW Fischer, MG Ottolini, JJ Mond |
Clinics in Perinatology | 1997 |
Streptococci and the Host
T Horaud, A Bouvet, R Leclercq, H de Montclos, M Sicard |
1997 | |
Immune responses to infectious diseases: an evolutionary perspective
KD Yang, HR Hill |
The Pediatric Infectious Disease Journal | 1996 |
Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons
LC Paoletti, RC Kennedy, TC Chanh, DL Kasper |
Infection and immunity | 1996 |
Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha
C Larsson, M Stålhammar-Carlemalm, G Lindahl |
Infection and immunity | 1996 |
Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci
PG Jerlström, SR Talay, P Valentin-Weigand, KN Timmis, GS Chhatwal |
Infection and immunity | 1996 |
Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women
K Hordnes, T Tynning, AI Kvam, R Jonsson, B Haneberg |
Infection and immunity | 1996 |
Synthesis and NMR assignment of two repeating units (decasaccharide) of the type III group B Streptococcus capsular polysaccharide and its 13C-labeled and N-propionyl substituted sialic acid analogues
W Zou, JR Brisson, QL Yang, M der Zwan, HJ Jennings |
Carbohydrate Research | 1996 |
Group B Streptococcus and Pregnancy
BM Mercer, RG Briggs |
Pediatric Annals | 1996 |
Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine model
SJ Devi, U Hayat, CE Frasch, AS Kreger, JG Morris |
Infection and immunity | 1995 |
Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes
E Lett, C Klopfenstein, JP Klein, M Schöller, D Wachsmann |
Infection and immunity | 1995 |
Group B Streptococcal Infections
CJ Baker, MS Edwards |
Annals of the New York Academy of Sciences | 1988 |